Entacavir is developed by Asian Institute Of Medical Sciences.

What development phase is Entacavir in?

Entacavir is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Entacavir

Asian Institute Of Medical Sciences · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Entacavir
Also known as	ETV
Sponsor	Asian Institute Of Medical Sciences
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Entacavir CI brief — competitive landscape report
Entacavir updates RSS · CI watch RSS
Asian Institute Of Medical Sciences portfolio CI